All LifeArc articles
-
NewsGroundbreaking new projects launched to lower the cost of monoclonal antibody production
LifeArc and the Gates Foundation have awarded more than $5m to seven projects aimed at developing cheaper and more efficient ways to produce monoclonal antibody (mAb) treatments. The innovative approaches include using filamentous fungus to produce mAbs.
-
NewsTransatlantic collaboration to develop therapeutic for Crimean-Congo Hemorrhagic Fever
A new transatlantic collaboration will look to develop an affordable and accessible monoclonal antibody therapeutic for Crimean-Congo Hemorrhagic Fever Virus (CCHFV), which could treat and protect thousands of people globally.
-
NewsFleming Initiative raises first £100m in the global fight against AMR
Three new partners have pledged additional funding and resources to the Fleming Initiative’s global effort to combat antimicrobial resistance (AMR), as leading medical expert Professor Lord Ara Darzi calls for tighter restrictions on the use of antibiotics.